Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-γ-carboxy prothrombin: A prospective study

Hepato-Gastroenterology

Volumn 49, Issue 43, 2002, Pages 235-238

  Ikoma, Jiro ^a   Kaito, Masahiko ^a   Ishihara, Tomoaki ^a   Nakagawa, Naoki ^a   Kamei, Akira ^a   Fujita, Naoki ^a   Iwasa, Motoh ^a   Tamaki, Shigenori ^a   Watanabe, Shozo ^a   Adachi, Yukihiko ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alpha fetoprotein; Des carboxy prothrombin; Early diagnosis; Enzyme immunoassay; Hepatocellular carcinoma; Recurrence

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN;

ADULT; AGED; ARTICLE; ASSAY; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER RECURRENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; PROTHROMBIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0036215258     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis
2. Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-γ-carboxy prothrombin and α-fetoprotein: A prospective study
3. Screening for hepatocellular carcinoma
4. Clinical evaluation of plasma des-γ-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes
5. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma
6. Plasma abnormal prothrombin levels in patients with small hepatocellular carcinoma
7. Plasma des-γ-carboxy prothrombin in the early stage of hepatocellular carcinoma
8. Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas
9. Usefulness of ED036 kit for measuring serum PIVKA-II levels in small hepatocellular carcinoma
10. The usefulness of determining des-γ-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma
11. Determination of serum des-gamma-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: Comparison of the conventional enzyme immunoassay and two modified methods
12. Serum-des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: Clinical significance in small hepatocellular carcinoma
13. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibody
14. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma
15. Des-γ-carboxy (abnormal) prothrombin and hepatocellular carcinoma: A critical review